Conservative versus Invasive Strategy in Elderly Patients with Non-ST-Elevation Myocardial Infarction: Insights from the International POPular Age Registry.
conservative strategy
coronary artery disease
elderly
invasive strategy
non-ST-elevation myocardial infarction
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
22 Aug 2023
22 Aug 2023
Historique:
received:
10
07
2023
revised:
15
08
2023
accepted:
18
08
2023
medline:
9
9
2023
pubmed:
9
9
2023
entrez:
9
9
2023
Statut:
epublish
Résumé
This registry assessed the impact of conservative and invasive strategies on major adverse clinical events (MACE) in elderly patients with non-ST-elevation myocardial infarction (NSTEMI). Patients aged ≥75 years with NSTEMI were prospectively registered from European centers and followed up for one year. Outcomes were compared between conservative and invasive groups in the overall population and a propensity score-matched (PSM) cohort. MACE included cardiovascular death, acute coronary syndrome, and stroke. The study included 1190 patients (median age 80 years, 43% female). CAG was performed in 67% (N = 798), with two-thirds undergoing revascularization. Conservatively treated patients had higher baseline risk. After propensity score matching, 319 patient pairs were successfully matched. MACE occurred more frequently in the conservative group (total population 20% vs. 12%,
Identifiants
pubmed: 37685517
pii: jcm12175450
doi: 10.3390/jcm12175450
pmc: PMC10487667
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : AstraZeneca
ID : ESR-16-11872
Organisme : St. Antonius Research Fund
Références
Ann Intern Med. 2004 Aug 3;141(3):186-95
pubmed: 15289215
Open Heart. 2022 Mar;9(1):
pubmed: 35354660
JACC Cardiovasc Interv. 2012 Sep;5(9):906-16
pubmed: 22995877
Lancet. 2016 Mar 12;387(10023):1057-1065
pubmed: 26794722
Chest. 2004 Aug;126(2):461-9
pubmed: 15302732
Cardiology. 2019;144(3-4):79-89
pubmed: 31689705
Eur Heart J. 2021 Apr 7;42(14):1289-1367
pubmed: 32860058
Circulation. 2011 Jun 14;123(23):2736-47
pubmed: 21670242
Eur Heart J. 2012 Mar;33(5):562-3
pubmed: 22285577
J Am Coll Cardiol. 2016 Jan 5;67(1):59-65
pubmed: 26764067
Eur Heart J. 2014 Jun 14;35(23):1551-8
pubmed: 24644310
Circ Cardiovasc Qual Outcomes. 2012 Sep 1;5(5):680-8
pubmed: 22991347
Eur Heart J. 2017 Mar 14;38(11):804-810
pubmed: 28363222
Int J Cardiol. 2018 Dec 1;272:26-32
pubmed: 30121176
Intern Med J. 2022 Jul;52(7):1167-1173
pubmed: 33647172
Circulation. 2019 Nov 12;140(20):1661-1678
pubmed: 31416350
J Am Heart Assoc. 2018 Jun 30;7(13):
pubmed: 29960995
EuroIntervention. 2021 May 17;17(1):67-74
pubmed: 33226000
Eur Heart J. 2019 Jan 14;40(3):237-269
pubmed: 30165617
Circulation. 2007 May 1;115(17):2340-3
pubmed: 17470708
Eur J Intern Med. 2016 Nov;35:89-94
pubmed: 27423981
Circulation. 2023 Jan 17;147(3):e32-e62
pubmed: 36503287
J Am Coll Cardiol. 2014 Dec 23;64(24):e139-e228
pubmed: 25260718
Scand Cardiovasc J. 2020 Oct;54(5):315-321
pubmed: 32586153
Lancet. 2020 Apr 25;395(10233):1374-1381
pubmed: 32334703
Eur Heart J. 2016 Nov 7;37(42):3232-3245
pubmed: 27523477
J Geriatr Cardiol. 2022 Oct 28;19(10):789-790
pubmed: 36338285